Evaluating the impact of a tertiary multidisciplinary meeting in metastatic breast cancer: A prospective study
Background: Metastatic breast cancer (mBC) guidelines recommend multidisciplinary meetings (MDM), but there is limited research on their impact. This prospective study examines the impact of an mBC MDM on management plans, their implementation rate, and costs and benefits at an Australian metropolit...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Breast |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977624001929 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823856879070085120 |
|---|---|
| author | Belinda Sassé Sammy Shaya Jessica Nimmo Katie Cao Daphne Day Katie Evans Catherine Healy Gwo-Yaw Ho Gillian Kruss Amelia McCartney Linda Mojzisova Ranjana Srivastava Jennifer Tan Mun Yee Tan Kate Webber Michelle White Steven David Marion Harris |
| author_facet | Belinda Sassé Sammy Shaya Jessica Nimmo Katie Cao Daphne Day Katie Evans Catherine Healy Gwo-Yaw Ho Gillian Kruss Amelia McCartney Linda Mojzisova Ranjana Srivastava Jennifer Tan Mun Yee Tan Kate Webber Michelle White Steven David Marion Harris |
| author_sort | Belinda Sassé |
| collection | DOAJ |
| description | Background: Metastatic breast cancer (mBC) guidelines recommend multidisciplinary meetings (MDM), but there is limited research on their impact. This prospective study examines the impact of an mBC MDM on management plans, their implementation rate, and costs and benefits at an Australian metropolitan breast cancer center. Methods: Consecutive mBC MDM patients were enrolled. Oncologists recorded their management plans before the MDM. Following the MDM, consensus plan was recorded and compared to the pre-MDM plan. Plans were categorised as no change, low impact, or high impact. High impact was defined as major treatment change or trial referral. Plan implementation was assessed four months post-MDM. Co-primary endpoints were proportion of plans changed pre/post-MDM and the proportion of high vs. low-impact changes. Estimates of time spent on the MDM and time savings were collected. Results: 114 MDM presentations for 95 patients were recorded from October 2023 to July 2024. 65 (57.0 %) presentations resulted in a plan change (p < 0.001); 32 (28.1 %) were high impact (p < 0.001). Follow up data was collected for 77 presentations; 65 (84.4 %) were fully implemented. 42 presentations resulted in high impact recommendations, of which 39 were implemented (92.6 %) (p = 0.005). The MDM earned $571.18/week with estimated costs of $1584.63, a $1013.45 deficit. Costs were likely offset by estimated savings from improved clinic efficiencies. Conclusion: MBC MDMs result in significant, actionable changes to patient management. 28.1 % of presentations resulted in treatment changes, almost all of which were implemented. Costs were offset by improved clinic efficiencies. MBC MDMs enhance care in this diverse patient population. |
| format | Article |
| id | doaj-art-0d6ac50c11f4473dbc88ac0672d651fc |
| institution | Kabale University |
| issn | 1532-3080 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Breast |
| spelling | doaj-art-0d6ac50c11f4473dbc88ac0672d651fc2025-02-12T05:30:36ZengElsevierBreast1532-30802025-02-0179103861Evaluating the impact of a tertiary multidisciplinary meeting in metastatic breast cancer: A prospective studyBelinda Sassé0Sammy Shaya1Jessica Nimmo2Katie Cao3Daphne Day4Katie Evans5Catherine Healy6Gwo-Yaw Ho7Gillian Kruss8Amelia McCartney9Linda Mojzisova10Ranjana Srivastava11Jennifer Tan12Mun Yee Tan13Kate Webber14Michelle White15Steven David16Marion Harris17Monash Health Breast Oncology, 823-865 Centre Rd, Bentleigh East, VIC, 3165 Australia; Corresponding author.Monash Health Breast Oncology, 823-865 Centre Rd, Bentleigh East, VIC, 3165 AustraliaMonash Health Breast Oncology, 823-865 Centre Rd, Bentleigh East, VIC, 3165 AustraliaMonash Health Breast Oncology, 823-865 Centre Rd, Bentleigh East, VIC, 3165 AustraliaMonash Health Breast Oncology, 823-865 Centre Rd, Bentleigh East, VIC, 3165 Australia; Monash University, Department of Medicine, Nursing and Health Sciences, Clayton, Victoria, AustraliaMonash Health Breast Oncology, 823-865 Centre Rd, Bentleigh East, VIC, 3165 AustraliaMonash Health Breast Oncology, 823-865 Centre Rd, Bentleigh East, VIC, 3165 AustraliaMonash Health Breast Oncology, 823-865 Centre Rd, Bentleigh East, VIC, 3165 Australia; Monash University, Department of Medicine, Nursing and Health Sciences, Clayton, Victoria, AustraliaMonash Health Breast Oncology, 823-865 Centre Rd, Bentleigh East, VIC, 3165 Australia; Monash University, Department of Medicine, Nursing and Health Sciences, Clayton, Victoria, AustraliaMonash Health Breast Oncology, 823-865 Centre Rd, Bentleigh East, VIC, 3165 Australia; Monash University, Department of Medicine, Nursing and Health Sciences, Clayton, Victoria, AustraliaMonash Health Breast Oncology, 823-865 Centre Rd, Bentleigh East, VIC, 3165 AustraliaMonash Health Breast Oncology, 823-865 Centre Rd, Bentleigh East, VIC, 3165 Australia; Monash University, Department of Medicine, Nursing and Health Sciences, Clayton, Victoria, AustraliaDepartment of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, AustraliaDepartment of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, AustraliaMonash Health Breast Oncology, 823-865 Centre Rd, Bentleigh East, VIC, 3165 AustraliaMonash Health Breast Oncology, 823-865 Centre Rd, Bentleigh East, VIC, 3165 Australia; Monash University, Department of Medicine, Nursing and Health Sciences, Clayton, Victoria, AustraliaDepartment of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; The Sir Peter MacCallum Department of Oncology, University of Melbourne, VIC, AustraliaMonash Health Breast Oncology, 823-865 Centre Rd, Bentleigh East, VIC, 3165 Australia; Monash University, Department of Medicine, Nursing and Health Sciences, Clayton, Victoria, AustraliaBackground: Metastatic breast cancer (mBC) guidelines recommend multidisciplinary meetings (MDM), but there is limited research on their impact. This prospective study examines the impact of an mBC MDM on management plans, their implementation rate, and costs and benefits at an Australian metropolitan breast cancer center. Methods: Consecutive mBC MDM patients were enrolled. Oncologists recorded their management plans before the MDM. Following the MDM, consensus plan was recorded and compared to the pre-MDM plan. Plans were categorised as no change, low impact, or high impact. High impact was defined as major treatment change or trial referral. Plan implementation was assessed four months post-MDM. Co-primary endpoints were proportion of plans changed pre/post-MDM and the proportion of high vs. low-impact changes. Estimates of time spent on the MDM and time savings were collected. Results: 114 MDM presentations for 95 patients were recorded from October 2023 to July 2024. 65 (57.0 %) presentations resulted in a plan change (p < 0.001); 32 (28.1 %) were high impact (p < 0.001). Follow up data was collected for 77 presentations; 65 (84.4 %) were fully implemented. 42 presentations resulted in high impact recommendations, of which 39 were implemented (92.6 %) (p = 0.005). The MDM earned $571.18/week with estimated costs of $1584.63, a $1013.45 deficit. Costs were likely offset by estimated savings from improved clinic efficiencies. Conclusion: MBC MDMs result in significant, actionable changes to patient management. 28.1 % of presentations resulted in treatment changes, almost all of which were implemented. Costs were offset by improved clinic efficiencies. MBC MDMs enhance care in this diverse patient population.http://www.sciencedirect.com/science/article/pii/S0960977624001929Breast cancerMulti-disciplinary careMetastaticPalliative careCancer Registry |
| spellingShingle | Belinda Sassé Sammy Shaya Jessica Nimmo Katie Cao Daphne Day Katie Evans Catherine Healy Gwo-Yaw Ho Gillian Kruss Amelia McCartney Linda Mojzisova Ranjana Srivastava Jennifer Tan Mun Yee Tan Kate Webber Michelle White Steven David Marion Harris Evaluating the impact of a tertiary multidisciplinary meeting in metastatic breast cancer: A prospective study Breast Breast cancer Multi-disciplinary care Metastatic Palliative care Cancer Registry |
| title | Evaluating the impact of a tertiary multidisciplinary meeting in metastatic breast cancer: A prospective study |
| title_full | Evaluating the impact of a tertiary multidisciplinary meeting in metastatic breast cancer: A prospective study |
| title_fullStr | Evaluating the impact of a tertiary multidisciplinary meeting in metastatic breast cancer: A prospective study |
| title_full_unstemmed | Evaluating the impact of a tertiary multidisciplinary meeting in metastatic breast cancer: A prospective study |
| title_short | Evaluating the impact of a tertiary multidisciplinary meeting in metastatic breast cancer: A prospective study |
| title_sort | evaluating the impact of a tertiary multidisciplinary meeting in metastatic breast cancer a prospective study |
| topic | Breast cancer Multi-disciplinary care Metastatic Palliative care Cancer Registry |
| url | http://www.sciencedirect.com/science/article/pii/S0960977624001929 |
| work_keys_str_mv | AT belindasasse evaluatingtheimpactofatertiarymultidisciplinarymeetinginmetastaticbreastcanceraprospectivestudy AT sammyshaya evaluatingtheimpactofatertiarymultidisciplinarymeetinginmetastaticbreastcanceraprospectivestudy AT jessicanimmo evaluatingtheimpactofatertiarymultidisciplinarymeetinginmetastaticbreastcanceraprospectivestudy AT katiecao evaluatingtheimpactofatertiarymultidisciplinarymeetinginmetastaticbreastcanceraprospectivestudy AT daphneday evaluatingtheimpactofatertiarymultidisciplinarymeetinginmetastaticbreastcanceraprospectivestudy AT katieevans evaluatingtheimpactofatertiarymultidisciplinarymeetinginmetastaticbreastcanceraprospectivestudy AT catherinehealy evaluatingtheimpactofatertiarymultidisciplinarymeetinginmetastaticbreastcanceraprospectivestudy AT gwoyawho evaluatingtheimpactofatertiarymultidisciplinarymeetinginmetastaticbreastcanceraprospectivestudy AT gilliankruss evaluatingtheimpactofatertiarymultidisciplinarymeetinginmetastaticbreastcanceraprospectivestudy AT ameliamccartney evaluatingtheimpactofatertiarymultidisciplinarymeetinginmetastaticbreastcanceraprospectivestudy AT lindamojzisova evaluatingtheimpactofatertiarymultidisciplinarymeetinginmetastaticbreastcanceraprospectivestudy AT ranjanasrivastava evaluatingtheimpactofatertiarymultidisciplinarymeetinginmetastaticbreastcanceraprospectivestudy AT jennifertan evaluatingtheimpactofatertiarymultidisciplinarymeetinginmetastaticbreastcanceraprospectivestudy AT munyeetan evaluatingtheimpactofatertiarymultidisciplinarymeetinginmetastaticbreastcanceraprospectivestudy AT katewebber evaluatingtheimpactofatertiarymultidisciplinarymeetinginmetastaticbreastcanceraprospectivestudy AT michellewhite evaluatingtheimpactofatertiarymultidisciplinarymeetinginmetastaticbreastcanceraprospectivestudy AT stevendavid evaluatingtheimpactofatertiarymultidisciplinarymeetinginmetastaticbreastcanceraprospectivestudy AT marionharris evaluatingtheimpactofatertiarymultidisciplinarymeetinginmetastaticbreastcanceraprospectivestudy |